• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血心脏再灌注时琥珀酸外排的机制。

Mechanism of succinate efflux upon reperfusion of the ischaemic heart.

机构信息

MRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.

Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Road, Cambridge CB2 0QQ, UK.

出版信息

Cardiovasc Res. 2021 Mar 21;117(4):1188-1201. doi: 10.1093/cvr/cvaa148.

DOI:10.1093/cvr/cvaa148
PMID:32766828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7983001/
Abstract

AIMS

Succinate accumulates several-fold in the ischaemic heart and is then rapidly oxidized upon reperfusion, contributing to reactive oxygen species production by mitochondria. In addition, a significant amount of the accumulated succinate is released from the heart into the circulation at reperfusion, potentially activating the G-protein-coupled succinate receptor (SUCNR1). However, the factors that determine the proportion of succinate oxidation or release, and the mechanism of this release, are not known.

METHODS AND RESULTS

To address these questions, we assessed the fate of accumulated succinate upon reperfusion of anoxic cardiomyocytes, and of the ischaemic heart both ex vivo and in vivo. The release of accumulated succinate was selective and was enhanced by acidification of the intracellular milieu. Furthermore, pharmacological inhibition, or haploinsufficiency of the monocarboxylate transporter 1 (MCT1) significantly decreased succinate efflux from the reperfused heart.

CONCLUSION

Succinate release upon reperfusion of the ischaemic heart is mediated by MCT1 and is facilitated by the acidification of the myocardium during ischaemia. These findings will allow the signalling interaction between succinate released from reperfused ischaemic myocardium and SUCNR1 to be explored.

摘要

目的

琥珀酸在缺血心脏中积累数倍,然后在再灌注时迅速氧化,导致线粒体产生活性氧物质。此外,大量积累的琥珀酸在再灌注时从心脏释放到循环中,可能会激活 G 蛋白偶联的琥珀酸受体 (SUCNR1)。然而,决定琥珀酸氧化或释放比例的因素以及这种释放的机制尚不清楚。

方法和结果

为了解决这些问题,我们评估了缺氧心肌细胞再灌注时以及离体和体内缺血心脏中积累的琥珀酸的命运。积累的琥珀酸的释放是选择性的,并受细胞内环境酸化的增强。此外,单羧酸转运蛋白 1 (MCT1) 的药理学抑制或单倍不足显著降低了再灌注心脏中琥珀酸的流出。

结论

缺血心脏再灌注时琥珀酸的释放是由 MCT1 介导的,并受到缺血期间心肌酸化的促进。这些发现将允许探索从再灌注缺血心肌释放的琥珀酸与 SUCNR1 之间的信号相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/d6d7f3de35e5/cvaa148f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/ccdd42921f07/cvaa148f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/52a2047c2faa/cvaa148f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/dc7dc82fa278/cvaa148f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/1b4812532df5/cvaa148f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/8486a0d2220b/cvaa148f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/ac12d7f78671/cvaa148f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/d6d7f3de35e5/cvaa148f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/ccdd42921f07/cvaa148f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/52a2047c2faa/cvaa148f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/dc7dc82fa278/cvaa148f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/1b4812532df5/cvaa148f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/8486a0d2220b/cvaa148f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/ac12d7f78671/cvaa148f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5f/7983001/d6d7f3de35e5/cvaa148f7.jpg

相似文献

1
Mechanism of succinate efflux upon reperfusion of the ischaemic heart.缺血心脏再灌注时琥珀酸外排的机制。
Cardiovasc Res. 2021 Mar 21;117(4):1188-1201. doi: 10.1093/cvr/cvaa148.
2
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.琥珀酸的缺血性积累通过线粒体活性氧控制再灌注损伤。
Nature. 2014 Nov 20;515(7527):431-435. doi: 10.1038/nature13909. Epub 2014 Nov 5.
3
Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart.增强线粒体丙酮酸代谢可改善心脏的缺血再灌注损伤。
JCI Insight. 2024 Jul 25;9(17):e180906. doi: 10.1172/jci.insight.180906.
4
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.遗传缺失或组蛋白去乙酰化酶 6 的药理学抑制通过限制实验性糖尿病中肿瘤坏死因子-α诱导的线粒体损伤来保护心脏免受缺血/再灌注损伤。
Cardiovasc Res. 2024 Oct 14;120(12):1456-1471. doi: 10.1093/cvr/cvae144.
5
Ischemic preconditioning protects against cardiac ischemia reperfusion injury without affecting succinate accumulation or oxidation.缺血预处理可防止心肌缺血再灌注损伤,而不影响琥珀酸的积累或氧化。
J Mol Cell Cardiol. 2018 Oct;123:88-91. doi: 10.1016/j.yjmcc.2018.08.010. Epub 2018 Aug 15.
6
Inhibiting Succinate Release Worsens Cardiac Reperfusion Injury by Enhancing Mitochondrial Reactive Oxygen Species Generation.抑制琥珀酸释放通过增强线粒体活性氧物种生成加重心脏再灌注损伤。
J Am Heart Assoc. 2022 Jul 5;11(13):e026135. doi: 10.1161/JAHA.122.026135. Epub 2022 Jun 29.
7
pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise.pH 门控琥珀酸分泌调节运动引起的肌肉重塑。
Cell. 2020 Oct 1;183(1):62-75.e17. doi: 10.1016/j.cell.2020.08.039. Epub 2020 Sep 17.
8
Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.通过抑制苹果酸 - 天冬氨酸穿梭来进行缺血前线粒体底物限制可在缺血再灌注后保留线粒体功能。
J Physiol. 2017 Jun 15;595(12):3765-3780. doi: 10.1113/JP273408. Epub 2017 Feb 27.
9
Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.氧化磷脂失活减轻心肌缺血再灌注损伤。
Cardiovasc Res. 2019 Jan 1;115(1):179-189. doi: 10.1093/cvr/cvy136.
10
Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo.丙二酸酯前药增强细胞内递送至体内对抗心肌缺血再灌注损伤。
Cardiovasc Drugs Ther. 2022 Feb;36(1):1-13. doi: 10.1007/s10557-020-07033-6. Epub 2020 Jul 9.

引用本文的文献

1
Identification of potential biomarkers of triton WR-1339 induced hyperlipidemia: NMR-based plasma metabolomics approach and gene expression analysis.Triton WR-1339诱导的高脂血症潜在生物标志物的鉴定:基于核磁共振的血浆代谢组学方法及基因表达分析
Metabolomics. 2025 Sep 4;21(5):132. doi: 10.1007/s11306-025-02318-z.
2
From Mechanisms to Diseases: The Succinate-GPR91 Axis in Cardiometabolic Diseases.从机制到疾病:心脏代谢疾病中的琥珀酸 - GPR91轴
J Cardiovasc Transl Res. 2025 Jul 24. doi: 10.1007/s12265-025-10670-7.
3
NDP52 deficiency accelerates chondrocyte degeneration through promoting pathogenic mitochondrial ROS via reverse electron transport.

本文引用的文献

1
Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation.琥珀酸积累导致器官移植过程中的缺血再灌注损伤。
Nat Metab. 2019 Sep 30;1:966-974. doi: 10.1038/s42255-019-0115-y.
2
Targeting Succinate Metabolism in Ischemia/Reperfusion Injury.靶向缺血/再灌注损伤中的琥珀酸代谢
Circulation. 2019 Dec 10;140(24):1968-1970. doi: 10.1161/CIRCULATIONAHA.119.042791. Epub 2019 Dec 9.
3
Succinate in ischemia: Where does it come from?琥珀酸在缺血中的来源:它来自哪里?
NDP52缺乏通过逆向电子传递促进致病性线粒体活性氧,从而加速软骨细胞退变。
Redox Biol. 2025 Jul 3;85:103747. doi: 10.1016/j.redox.2025.103747.
4
RNA-ssisting immunity to heal the heart: a new frontier in therapeutics.RNA辅助心脏修复免疫:治疗学的新前沿
Cardiol Plus. 2025 Apr-Jun;10(2):129-144. doi: 10.1097/CP9.0000000000000116. Epub 2025 Jun 24.
5
Local arterial administration of acidified malonate as an adjunct therapy to mechanical thrombectomy in ischemic stroke.局部动脉注射酸化丙二酸盐作为缺血性中风机械取栓术的辅助治疗。
Cardiovasc Res. 2025 Aug 14;121(9):1407-1418. doi: 10.1093/cvr/cvaf118.
6
Immunometabolism in heart failure.心力衰竭中的免疫代谢
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01165-8.
7
Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype.2型糖尿病会使患有射血分数保留的心力衰竭(HFpEF)心脏代谢表型的女性ST段抬高型心肌梗死(STEMI)患者和雌性db/db小鼠的缺血/再灌注结果恶化。
Cardiovasc Diabetol. 2025 Jun 7;24(1):243. doi: 10.1186/s12933-025-02771-z.
8
Mechanical unloading is accompanied by reverse metabolic remodelling in the failing heart: Identification of a novel citraconate-mediated pathway.机械卸载伴随着衰竭心脏的逆向代谢重塑:一种新型柠檬酸盐介导途径的鉴定。
Eur J Heart Fail. 2025 Jul;27(7):1342-1352. doi: 10.1002/ejhf.3704. Epub 2025 Jun 4.
9
Metabolic Adaptations and Therapies in Cardiac Hypoxia: Mechanisms and Clinical Implications/ Potential Strategies.心脏缺氧时的代谢适应与治疗:机制、临床意义及潜在策略
JACC Basic Transl Sci. 2025 Apr 2. doi: 10.1016/j.jacbts.2024.12.008.
10
Targeting Lactic Acid Modification in Ischemic Heart Diseases: Novel Therapeutics and Mechanism.靶向缺血性心脏病中的乳酸修饰:新型疗法与机制
J Cardiovasc Transl Res. 2025 Apr;18(2):257-267. doi: 10.1007/s12265-025-10593-3. Epub 2025 Feb 7.
Int J Biochem Cell Biol. 2019 Oct;115:105580. doi: 10.1016/j.biocel.2019.105580. Epub 2019 Aug 5.
4
High-fat diet improves tolerance to myocardial ischemia by delaying normalization of intracellular PH at reperfusion.高脂饮食通过延迟再灌注时细胞内 PH 值的正常化来提高心肌缺血的耐受性。
J Mol Cell Cardiol. 2019 Aug;133:164-173. doi: 10.1016/j.yjmcc.2019.06.001. Epub 2019 Jun 10.
5
SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity.SUCNR1 控制巨噬细胞中的抗炎程序,以调节对肥胖的代谢反应。
Nat Immunol. 2019 May;20(5):581-592. doi: 10.1038/s41590-019-0372-7. Epub 2019 Apr 8.
6
Protection against cardiac ischemia-reperfusion injury by hypothermia and by inhibition of succinate accumulation and oxidation is additive.低温和抑制琥珀酸积累和氧化可增加对心肌缺血再灌注损伤的保护作用。
Basic Res Cardiol. 2019 Mar 15;114(3):18. doi: 10.1007/s00395-019-0727-0.
7
Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis.选择性线粒体超氧化物生成在体内通过应激反应具有心脏保护作用。
Free Radic Biol Med. 2019 Apr;134:678-687. doi: 10.1016/j.freeradbiomed.2019.01.034. Epub 2019 Feb 4.
8
Selective Disruption of Mitochondrial Thiol Redox State in Cells and In Vivo.选择性破坏细胞和体内的线粒体硫醇氧化还原状态。
Cell Chem Biol. 2019 Mar 21;26(3):449-461.e8. doi: 10.1016/j.chembiol.2018.12.002. Epub 2019 Jan 31.
9
Succinate receptor mediates intestinal inflammation and fibrosis.琥珀酸受体介导肠道炎症和纤维化。
Mucosal Immunol. 2019 Jan;12(1):178-187. doi: 10.1038/s41385-018-0087-3. Epub 2018 Oct 2.
10
Ischemic preconditioning protects against cardiac ischemia reperfusion injury without affecting succinate accumulation or oxidation.缺血预处理可防止心肌缺血再灌注损伤,而不影响琥珀酸的积累或氧化。
J Mol Cell Cardiol. 2018 Oct;123:88-91. doi: 10.1016/j.yjmcc.2018.08.010. Epub 2018 Aug 15.